XPM yields 10.57% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 8
Combined, XPM + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of XPM + MRK for your $10,000?
Tidal Trust II - Defiance Daily Target 2x Long PM ETF is an exchange traded fund launched and managed by Tidal Investments LLC. It invests in public equity and fixed income markets. For its equity portion, the fund invests through derivatives in stocks of companies operating across consumer discretionary, consumer discretionary distribution and retail, distributors, non-durable goods distribution, alcoholic beverage and tobacco distribution, tobacco distribution, consumer staples, food, beverage and tobacco, tobacco, cigarettes and nicotine sectors. The fund uses derivatives such as options and swaps to create its portfolio. It invests in growth and value stocks of companies across diversified market capitalization. For its fixed income portion, the fund invests directly and through other funds in U.S. Government securities, short term bond and corporate debt securities. Tidal Trust II - Defiance Daily Target 2x Long PM ETF was formed on September 3, 2025 and is domiciled in the United States.
Full XPM Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.